Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0000950170-23-041534
Filing Date
2023-08-10
Accepted
2023-08-10 19:05:25
Documents
1
Period of Report
2023-08-10

Document Format Files

Seq Description Document Type Size
1 4 ownership.html 4  
1 4 ownership.xml 4 3846
  Complete submission text file 0000950170-23-041534.txt   5170
Mailing Address 200 - 3650 GILMORE WAY BURNABY A1 V5G 48W
Business Address 200 - 3650 GILMORE WAY BURNABY A1 V5G 48W (604) 484-3300
Xenon Pharmaceuticals Inc. (Issuer) CIK: 0001582313 (see all company filings)

EIN.: 980661854 | State of Incorp.: A1 | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations

Mailing Address SOVEREIGN HOUSE, VISION PARK, HISTON CAMBRIDGE X0 CB24 9BZ
Business Address
Gover Justin D. (Reporting) CIK: 0001754129 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-36687 | Film No.: 231161096